Dr. Dawn debunks the common misconception about extra virgin olive oil's smoke point indicating oxidation damage, citing new research showing it remains stable and safe even at high cooking temperatures due to its high flavenoid and antioxidant content.

She discusses critical timing factors for surgical procedures, sharing research that reveals a "weekend effect" with 9-12% higher mortality rates for surgeries performed on Fridays compared to early-week procedures.

The show examines promising AI technology that can detect depression and other mental health conditions through voice patterns alone, potentially improving diagnosis in diverse populations regardless of language barriers.

A caller asks about measles vaccines and Robert Kennedy Jr.'s controversial claims, with Dr. Dawn explaining different vaccine types and clarifying that while live virus vaccines can technically cause disease in immunocompromised individuals, this is extremely rare and preventable.

Dr. Dawn explores the landmark "Nun Study" tracking 678 nuns over 30 years, highlighting discoveries about cognitive resilience including how early-life linguistic abilities correlate with reduced dementia risk and how some individuals remain mentally sharp despite having Alzheimer's brain pathology.

The show discusses promising research on transcranial direct current stimulation for Alzheimer's patients, showing how electrical stimulation of specific brain regions improved verbal learning and word production abilities for up to eight weeks.

Dr. Dawn examines psychological factors associated with dementia risk, noting that while negative thinking patterns correlate with cognitive decline, determining causality remains challenging.

She shares a breakthrough in ALS research identifying neurofilament light chain proteins as a potential biomarker that correctly identified people with ALS more than 80% of the time and predicted survival rates.

The show concludes with fascinating microbiome research on bile acids, explaining how gut bacteria transform liver-produced bile and how certain microbial bile acids can either promote or inhibit inflammatory bowel disease and colon cancer development.